Growth differentiation factor 15 is associated with diabetic kidney disease severity and attenuates ferroptosis-related injury and inflammation in renal tubular epithelial cells
This study demonstrates that while elevated circulating Growth Differentiation Factor 15 (GDF15) is associated with the severity of diabetic kidney disease, it plays a protective role in renal tubular epithelial cells by attenuating glucolipotoxicity-induced ferroptosis and inflammation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Diabetes is a condition where the body struggles to manage sugar, and over time, this excess sugar can damage the delicate filters inside the kidneys. While doctors often focus on the kidney's filtering units, the tiny tubes that carry urine away are also under constant attack. When these tubes are exposed to high sugar and high fat levels, they can suffer a specific kind of cellular damage where iron inside the cell causes the cell's own fats to rust and rot, leading to cell death. This process, known as ferroptosis, is like a slow, internal corrosion that weakens the kidney's ability to function. At the same time, the body's immune system often flares up in response, creating inflammation that makes the damage worse. Scientists have long searched for signals in the blood that could tell them how severe this damage is, and one such signal, a protein called growth differentiation factor 15, has been noticed rising in people with kidney trouble. However, it remained a mystery whether this rising signal was simply a warning siren for damage or if the protein itself was trying to help the cells survive.
A team of researchers set out to solve this puzzle by looking at both human patients and kidney cells in the lab. They gathered blood samples from three groups of people: healthy individuals, people with type 2 diabetes who had not yet developed kidney disease, and people with diabetes who had already suffered significant kidney damage. When they measured the levels of the protective protein in these samples, they found a clear pattern. The protein levels were lowest in the healthy group, higher in the group with diabetes but no kidney damage, and highest in the group with severe kidney disease. The amount of this protein in the blood rose and fell in step with how badly the kidneys were failing. It also moved in the opposite direction of the body's natural defenses against rusting fats and in the same direction as markers of inflammation and iron imbalance. This suggested that the protein was deeply connected to the state of the kidney, but because the study only looked at a single moment in time, it could not yet prove whether the protein was causing the harm or trying to fix it.
To find the answer, the researchers turned to a model of human kidney cells grown in a dish. They exposed these cells to a mixture of high sugar and high fat, mimicking the harsh environment inside a diabetic body. As expected, the cells began to show signs of the rusting damage, with their internal iron levels rising and their protective antioxidants falling. At the same time, the cells started producing more of the protective protein. The researchers then performed a delicate experiment: they used genetic tools to either remove the protein from the cells or force the cells to make too much of it. When they removed the protein, the cells suffered much worse damage from the sugar and fat mixture; the iron levels spiked higher, the protective antioxidants vanished faster, and the cells died more readily. Conversely, when they forced the cells to produce extra amounts of the protein, the cells became much more resilient. The extra protein helped keep the iron levels in check, preserved the antioxidants, and reduced the inflammation that usually follows this type of injury.
The study also revealed how the protein achieved this protection. It appeared to work by regulating how the cells handled iron and by calming down the inflammatory signals that often make cell death worse. When the protein was missing, the cells lost their ability to store iron safely and became overwhelmed by the toxic rusting process. When the protein was present, it helped the cells maintain a balance, preventing the iron from causing the fatal corrosion. The researchers also used a known chemical that stops this rusting process to confirm their findings. When they added this chemical to cells that were missing the protective protein, it helped the cells survive, proving that the damage caused by the lack of the protein was indeed driven by this rusting mechanism.
These findings suggest that the rising levels of the protein seen in patients are likely a sign that the body is trying to fight back against the damage, rather than the cause of the problem itself. The protein appears to act as a shield, helping kidney cells withstand the toxic mix of sugar and fat that characterizes diabetes. While the study does not yet prove that giving this protein to patients would cure kidney disease, it provides strong evidence that the protein plays a vital protective role. The research highlights a complex relationship where the body's stress response tries to limit the spread of cellular rust and inflammation. By understanding how this protein works to keep iron levels stable and inflammation low, scientists may one day find new ways to protect the kidneys from the slow, damaging effects of diabetes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.